Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Maeurer

Showing results (81-90 of 206) with videos related to

Pageof 21
Sort By:
Tuberculosis (Edinburgh, Scotland)|January 22, 2011
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and controlJustin O'Grady, Michael Hoelscher, Rifat Atun, et al.
The Lancet. Infectious Diseases|March 28, 2013
Tuberculosis biomarkers discovery: developments, needs, and challengesRobert S Wallis, Peter Kim, Stewart Cole, et al.
Plos One|April 5, 2013
A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosisRebecca Axelsson-Robertson, André G Loxton, Gerhard Walzl, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 15, 2017
Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapyTumaini Nagu, Said Aboud, Martin Rao, et al.
Cells|March 13, 2024
Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell TherapyAndreia Maia, Mubin Tarannum, Joana R Lérias, et al.
Plos One|April 28, 2016
No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 VaccinationFavelle Lamb, Alexander Ploner, Katharina Fink, et al.
Frontiers in Immunology|July 18, 2017
Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic ReviewVera M Kroesen, Matthias I Gröschel, Neil Martinson, et al.
Plos One|November 13, 2012
Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising markerEmilie Borgström, Peter Andersen, Fredrik Atterfelt, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 6, 2017
Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB modelMartin Rao, Nathalie Cadieux, Megan Fitzpatrick, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Progress in tuberculosis vaccine development and host-directed therapies--a state of the art reviewStefan H E Kaufmann, Christoph Lange, Martin Rao, et al.
Pageof 21

Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Tuberculosis (Edinburgh, Scotland)|January 22, 2011
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and controlJustin O'Grady, Michael Hoelscher, Rifat Atun, et al.
The Lancet. Infectious Diseases|March 28, 2013
Tuberculosis biomarkers discovery: developments, needs, and challengesRobert S Wallis, Peter Kim, Stewart Cole, et al.
Plos One|April 5, 2013
A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosisRebecca Axelsson-Robertson, André G Loxton, Gerhard Walzl, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 15, 2017
Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapyTumaini Nagu, Said Aboud, Martin Rao, et al.
Cells|March 13, 2024
Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell TherapyAndreia Maia, Mubin Tarannum, Joana R Lérias, et al.
Plos One|April 28, 2016
No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 VaccinationFavelle Lamb, Alexander Ploner, Katharina Fink, et al.
Frontiers in Immunology|July 18, 2017
Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic ReviewVera M Kroesen, Matthias I Gröschel, Neil Martinson, et al.
Plos One|November 13, 2012
Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising markerEmilie Borgström, Peter Andersen, Fredrik Atterfelt, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 6, 2017
Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB modelMartin Rao, Nathalie Cadieux, Megan Fitzpatrick, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Progress in tuberculosis vaccine development and host-directed therapies--a state of the art reviewStefan H E Kaufmann, Christoph Lange, Martin Rao, et al.
Pageof 21